Review of Prognostic Testing for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Review Articles
Donata Pakeltytė
Vilnius University image/svg+xml
Birutė Burnytė
Vilnius University image/svg+xml
Published 2024-12-01
https://doi.org/10.15388/NS.2024.28.102.3
PDF
HTML

Keywords

prognostic genetic testing
amyotrophic lateral sclerosis
frontotemporal dementia
C9orf72 repeat expansion

How to Cite

1.
Pakeltytė D, Burnytė B. Review of Prognostic Testing for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. NS [Internet]. 2024 Dec. 1 [cited 2025 Nov. 6];28(4(102):238-44. Available from: https://www.zurnalai.vu.lt/neurologijos_seminarai/article/view/43729

Abstract

Frontotemporal dementia and amyotrophic lateral sclerosis are neurodegenerative diseases with distinc clinical presentation, but interconnected with each other. Frontotemporal dementia most often presents as behavioural or speech impairment, whereas amyotrophic lateral sclerosis presents as progressive weakness of voluntary muscles. C9orf72 repeat expansion is the most common genetic cause of both diseases although there are more causative genes for these diseases separately. As the knowledge of frontotemporal dementia and amyotrophic lateral sclerosis is expanding, more relatives of affected patiens inquire about prognostic testing. Unfortunatelly, there are no definitive recommendations for prognostic testing and because of partial penetrance of causative gene variants and unknown genetic cause of high number of cases, clinical interpretation of prognostic testing is complicated.
This article provides review of recommendations and limitations of prognostic testing for frontotemporal dementia and amyotrophic lateral sclerosis.

PDF
HTML
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Downloads

Download data is not yet available.